.Exelixis is quiting on its tissue element (TF)- targeting antibody-drug conjugate after concluding ...
.Three weeks after Roche's Genentech system walked away from an SHP2 prevention pact, Relay Therapeu...
.Stoke Therapeutics' Dravet disorder medicine has actually been devoid of a predisposed hold, gettin...
.Tough Biotech Affiliate Publisher Gabrielle Masson showed the 2024 course of Ferocious 15 victors o...
.Novo Nordisk has actually axed its once-monthly double GLP-1/ GIP receptor agonist, ending (PDF) ad...
.Merck & Co. has rapidly gotten back a number of the expenses of its own Harp on Therapeutics buy...
.After BioMarin carried out a springtime clean of its pipe in April, the business has actually deter...
.Big Pharmas continue to be stuck to the idea of molecular glue degraders. The current firm to find ...
.A brand-new worldwide life science credit report agency, referred to as Symbiotic Resources, has re...
.Bristol Myers Squibb is axing yet another large bet from the Caforio era, canceling a bargain for A...